Allschwil
-
Franchise India Bureau Sep 29 2017 - 1 min readJohnson & Johnson agreed to buy Actelion Ltd for USD30 billion and spin off the Swiss drugmaker's research and development operations, clinching its largest deal ever to become a leader in medicines for a rare type of high blood pressure.J&J, one of the world's biggest maker of health-care products, is fulfilling its goal of gaining ...